Full Press Release Details
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences. AtriCure’s management is scheduled to participate in a fireside discussion on Monday, November 9, 2026, at 11:00 a.m. Eastern Standard Time at the UBS Global Healthcare Conference.